Hippocratic AI, a Palo Alto-based generative AI company developing safety-focused large language models (LLMs) for healthcare, has raised $141 million in a Series B funding round, bringing its valuation to $1.64 billion. The round was led by Kleiner Perkins, with participation from existing investors including SV Angel, Premji, General Catalyst, Andreessen Horowitz (a16z), NVIDIA, Universal Health Services, and WellSpan Health. The funds will support the company’s expansion into new markets such as pharmaceuticals and the payor sector, as well as into regions like EMEA, Latin America, and Southeast Asia.
Founded in 2023 by CEO Munjal Shah and a team of healthcare and AI experts, Hippocratic AI focuses on non-diagnostic tasks such as medication onboarding, policy queries, and EHR assistance. The company recently launched its AI Agent App Store, empowering licensed clinicians to design and implement AI agents that improve workflow efficiency and patient care. These agents, which can be set up in under 30 minutes, undergo rigorous safety testing by both the clinicians and Hippocratic AI staff. With its innovative approach and strong financial backing, Hippocratic AI is poised to reshape healthcare delivery by combining advanced AI with deep clinical expertise.
Read the full article here